CymaBay Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
CymaBay Therapeutics, Inc.
CIK #0001042074
EDGAR Form CIK 2011 - 2025
10-K [0001042074]
10-Q [0001042074]
3 [0001042074]
4 [0001042074]
8-K [0001042074]
D [0001042074]
SC 13D [0001042074]
SC 13G [0001042074]
Form 13D/13G Filer Form 13D/13G Subject Filed
Janus Henderson Group PLC CymaBay Therapeutics Inc [2024-02-14]
Vanguard Group Inc CymaBay Therapeutics Inc [2024-02-13]
BlackRock Inc CymaBay Therapeutics Inc [2024-01-25]
RA Capital Management LP CymaBay Therapeutics Inc [2023-09-22]
Adage Capital Partners GP LLC CymaBay Therapeutics Inc [2023-09-11]
Perceptive Advisors LLC CymaBay Therapeutics Inc [2023-03-10]
BlackRock Inc CymaBay Therapeutics Inc [2022-07-08]
TCG Crossover Management LLC CymaBay Therapeutics Inc [2021-11-29]
Commodore Capital LP CymaBay Therapeutics Inc [2021-07-12]
Boxer Capital LLC CymaBay Therapeutics Inc [2020-09-24]
View All
Form 3/4/5 Subject 2011 - 2025
CymaBay Therapeutics, Inc.
Wiggans Thomas G
Emster Kurt von
Loewy Caroline M
McWherter Charles
Lefebvre Eric
Dorling Janet
Shantharam Harish
Dickinson Klara
Quinlan Paul T
Wills Robert James
Shah Sujal
Menold Daniel
Aghazadeh Behzad
Avoro Capital Advisors LLC
Kim Dennis D
Stuart Lewis J
Truex Paul F
von Emster Kurt
Goldfischer Carl
Booth Robert F.
Boudes Pol F
Weiland Robert J.
Stein Evan A
Martin Robert L.
OMara Patrick J.
Rosemark Kirk
Van Wart Harold
Lange Louis G
Kumar Hari
Penhoet Edward
Versant Side Fund II, LP
Versant Venture Capital II, LP
Versant Affiliates Fund II-A, LP
Alta Biopharma Partners III LP
Alta Biopharma Partners III GmbH & Co Beteiligungs KG
Alta Embarcadero Biopharma Partners III LLC
Terms | Privacy | Guide
tony@aum13f.com